Inpatient Admissions and Re-Admissions in Medicare Beneficiaries Initiating Umeclidinium/Vilanterol or Tiotropium Therapy.

Michael BogartGary Yat-Hung LeungAnissa CyhaniukKristi K DiRocco

Published in: International journal of chronic obstructive pulmonary disease (2024)

Patients with COPD using Medicare in the US and receiving UMEC/VI or TIO reported similar time-to-first inpatient admission and similar proportion of re-admissions.

Keyphrases

palliative care
mental health
chronic obstructive pulmonary disease
emergency department
acute care
affordable care act
healthcare
stem cells
quantum dots
mesenchymal stem cells
air pollution
cell therapy
smoking cessation